Australia markets closed
  • ALL ORDS

    6,971.60
    +28.60 (+0.41%)
     
  • AUD/USD

    0.7713
    +0.0031 (+0.40%)
     
  • ASX 200

    6,739.60
    +28.80 (+0.43%)
     
  • OIL

    67.46
    +1.37 (+2.07%)
     
  • GOLD

    1,704.90
    +6.40 (+0.38%)
     
  • BTC-AUD

    65,991.46
    +1,631.54 (+2.54%)
     
  • CMC Crypto 200

    1,031.46
    +88.29 (+9.36%)
     

The Global Hepatitis C Drugs Market is expected to grow by $ 252.89 mn during 2021-2025 progressing at a CAGR of 1% during the forecast period

ReportLinker
·2-min read

Global Hepatitis C Drugs Market 2021-2025 The analyst has been monitoring the hepatitis C drugs market and it is poised to grow by $ 252. 89 mn during 2021-2025 progressing at a CAGR of 1% during the forecast period.

New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hepatitis C Drugs Market 2021-2025" - https://www.reportlinker.com/p05729098/?utm_source=GNW
Our report on hepatitis C drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for direct-acting antivirals and rising number of patient support initiatives. In addition, increasing demand for direct-acting antivirals is anticipated to boost the growth of the market as well.
The hepatitis C drugs market analysis includes product segments and geographical landscapes.

The hepatitis C drugs market is segmented as below:
By Product
• Combination therapy
• Monotherapy

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the high prevalence of hepatitis C as one of the prime reasons driving the hepatitis C drugs market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatitis C drugs market covers the following areas:
• Hepatitis C drugs market sizing
• Hepatitis C drugs market forecast
• Hepatitis C drugs market industry analysis


Read the full report: https://www.reportlinker.com/p05729098/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001